Back to search
Acute Ischemic Stroke, Cerebral Embolism and Thrombosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Ischemic Stroke, Cerebral Embolism and Thrombosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Ischemic Stroke, Cerebral Embolism and Thrombosis trials you may qualify forA phase III, multicentre, prospective, randomised, open-label, blinded-endpoint clinical trial will evaluate two thrombolytic agents for the treatment of acute…
A prospective, open label study designed to assess the safety, performance and efficacy of thrombus removal in subjects presenting with acute ischemic stroke wi…
Safe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may reduce the transmission of and achieve population immunity against…
STARS is a prospective, multicentre, open-label, dose escalation, Phase IIa study to assess the safety and tolerability of TBO-309, an adjuvant antiplatelet the…
Rationale: Cardiac CT acquired during the acute stroke imaging protocol (acute cardiac CT) has recently been shown to have a superior diagnostic yield than tra…
A Multicenter Registry of Endovascular Treatment for Acute Ischemic Stroke.
This study will include adults (ages 18-80) who have had a stroke caused by a large blood clot blocking blood flow in the brain. All patients in the study must…
Left ventricular thrombus is found in 10 to 25% of patients with impaired left ventricular function following ST-segment elevation myocardial infarction and up…
The aim of the AIS of HEARTS registry is to establish a database to collect, maintain and provide accessible individual patient data from international cohorts…